SCHEMBL2225795

SCHEMBL2225795

NS(=O)(=O)c1cccc(CNc2cc(Nc3cc(Cl)c(O)c(Cl)c3)ncn2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 3/20 0.46
JAK3 P52333 4/20 0.45
CA1 P00915 2/20 0.42
ACHE P22303 1/20 0.42
EGFR P00533 4/20 0.41
ERBB3 P21860 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
TNNI3K Q59H18 3/20 0.40
CCNT1 O60563 1/20 0.40
CDK9 P50750 1/20 0.40
JAK1 P23458 2/20 0.40
PTK2 Q05397 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224478 0.91 NTRK1 (0.47) NTRK1JAK3CA1ACHEEGFR
SCHEMBL2226138 0.85 TNNI3K (0.57) NTRK1JAK3EGFRERBB3CDK1
SCHEMBL2225663 0.81 EGFR (0.59) JAK3EGFRERBB3CDK1CCNB1
SCHEMBL2224393 0.81 NTRK1 (0.45) NTRK1CA1PTK2CA12CA2
SCHEMBL2224438 0.81 TNNI3K (0.57) NTRK1JAK3EGFRERBB3TNNI3K
SCHEMBL2225416 0.81 NTRK1 (0.56) NTRK1JAK3EGFRERBB3CDK2
SCHEMBL2228327 0.80 CYP1A2 (0.52) NTRK1JAK3EGFRERBB3TNNI3K
SCHEMBL2224234 0.79 TNNI3K (0.43) CA1ACHEEGFRERBB3CDK1
SCHEMBL2226983 0.79 CA1 (0.46) NTRK1JAK3CA1EGFRERBB3
SCHEMBL2225667 0.78 JAK1 (0.47) JAK3EGFRERBB3CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed